ArticleBMC genomics2025
Genome-wide identification and expression profiling of MYB transcription factors in Artemisia argyi.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Molecular and Physiological Insights into CAT- and SOD-Associated Redox Homeostasis Under Salt Stress inInternational journal of molecular sciences · 2026Article
- Genome-Wide Characterization and Light-Responsive Expression Patterns of B-Box Transcription Factors inPlants (Basel, Switzerland) · 2026Article
- Genome-wide identification and expression analysis of the MYB transcription factor family inFrontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Artemisia argyi, a significant medicinal plant in China, is known for its high content of essential oils, flavonoids, and other bioactive compounds. MYB transcription factors are the largest gene family in plants and are widely reported to play important roles in plant development, metabolism, defense, and stress resistance. However, the MYB family of A. argyi has not been systematically studied. The aim of this study was to comprehensively analyze the MYB gene family of A. argyi and explore its potential role in flavonoid biosynthesis. Here, the phylogeny, chromosome location, gene structure, cis-acting elements, expression patterns and Gene ontology (GO) annotation of MYB gene family members were investigated using bioinformatics methods based on the whole-genome and transcriptome data of A. argyi. In total, 227 AYMYB transcription factors were identified from A. argyi genome, including 22 1R-MYB, 165 R2R3-MYB, 16 3R-MYB, 5 4R-MYB and 19 atypical MYB members. These AYMYBs were unevenly distributed across the A. argyi genome. Subcellular localization prediction revealed that all the AYMYBs were localized in the nucleus. The protein motifs, conserved domains, and gene structures of AYMYBs were identified, and the results showed that AYMYBs from the same subfamily exhibited similar motifs and gene structures. Cis-acting elements and GO analysis suggested that AYMYBs may be involved in many biological processes related to plant development, metabolism, defense, and stress resistance. Moreover, quantitative real-time PCR (qRT-PCR) analysis showed that approximately 50 genes showed high expression levels in the leaves of A. argyi and AYMYBs showed specific expression patterns under MeJA treatment. Together, our research will offer useful information for future investigations into the functions of MYB genes in A. argyi, especially in regulating the process of flavonoid biosynthesis in leaves and in response to MeJA treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.